首页> 美国卫生研究院文献>PLoS Clinical Trials >LIS1 Regulates Osteoclast Formation and Function through Its Interactions with Dynein/Dynactin and Plekhm1
【2h】

LIS1 Regulates Osteoclast Formation and Function through Its Interactions with Dynein/Dynactin and Plekhm1

机译:LIS1通过与Dynein / Dynactin和Plekhm1的相互作用调节破骨细胞的形成和功能。

代理获取
本网站仅为用户提供外文OA文献查询和代理获取服务,本网站没有原文。下单后我们将采用程序或人工为您竭诚获取高质量的原文,但由于OA文献来源多样且变更频繁,仍可能出现获取不到、文献不完整或与标题不符等情况,如果获取不到我们将提供退款服务。请知悉。

摘要

Microtubule organization and lysosomal secretion are both critical for the activation and function of osteoclasts, highly specialized polykaryons that are responsible for bone resorption and skeletal homeostasis. Here, we have identified a novel interaction between microtubule regulator LIS1 and Plekhm1, a lysosome-associated protein implicated in osteoclast secretion. Decreasing LIS1 expression by shRNA dramatically attenuated osteoclast formation and function, as shown by a decreased number of mature osteoclasts differentiated from bone marrow macrophages, diminished resorption pits formation, and reduced level of CTx-I, a bone resorption marker. The ablated osteoclast formation in LIS1-depleted macrophages was associated with a significant decrease in macrophage proliferation, osteoclast survival and differentiation, which were caused by reduced activation of ERK and AKT by M-CSF, prolonged RANKL-induced JNK activation and declined expression of NFAT-c1, a master transcription factor of osteoclast differentiation. Consistent with its critical role in microtubule organization and dynein function in other cell types, we found that LIS1 binds to and colocalizes with dynein in osteoclasts. Loss of LIS1 led to disorganized microtubules and aberrant dynein function. More importantly, the depletion of LIS1 in osteoclasts inhibited the secretion of Cathepsin K, a crucial lysosomal hydrolase for bone degradation, and reduced the motility of osteoclast precursors. These results indicate that LIS1 is a previously unrecognized regulator of osteoclast formation, microtubule organization, and lysosomal secretion by virtue of its ability to modulate dynein function and Plekhm1.
机译:微管的组织和溶酶体分泌对于破骨细胞的活化和功能都至关重要,破骨细胞是高度专门化的多核体,负责骨骼的吸收和骨骼的体内平衡。在这里,我们已经确定了微管调节剂LIS1和Plekhm1之间的新型相互作用,Plekhm1是与破骨细胞分泌有关的溶酶体相关蛋白。 shRNA降低LIS1表达可显着减弱破骨细胞的形成和功能,这与从骨髓巨噬细胞分化出来的成熟破骨细胞数量减少,吸收凹坑形成减少以及CTx-I(一种骨吸收标记物)水平降低所表明。 LIS1耗竭的巨噬细胞中破骨细胞的形成与巨噬细胞增殖,破骨细胞存活和分化的显着降低有关,这是由于M-CSF的ERK和AKT激活减少,RANKL诱导的JNK激活时间延长和NFAT表达下降所致-c1,破骨细胞分化的主要转录因子。与它在其他细胞类型中的微管组织和达因功能中的关键作用相一致,我们发现LIS1与破骨细胞中的达因结合并共定位。 LIS1的丢失导致微管紊乱和动力蛋白异常。更重要的是,破骨细胞中LIS1的消耗抑制了组织蛋白酶K的分泌,而组织蛋白酶K是骨降解的关键溶酶体水解酶,并降低了破骨细胞前体的运动能力。这些结果表明,LIS1凭借其调节动力蛋白功能和Plekhm1的能力,是破骨细胞形成,微管组织和溶酶体分泌的先前无法识别的调节剂。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
代理获取

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号